We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/1/2019 08:33 | To be honest the DTC issue did surprise me, but I've now realised I haven't been seeing as many skinny tan posts on my feed.It's another reason why diversification in brands and sales channels is important.I think the Boots deal will be transformational as we will now have three strong channels for the biggest brand. (DTC, superdrug and Boots).Roots and Charles and Lee seem to be doing well and hopefully prolong launch will boost the life sciences division.Short term it's all about Boots. St tropez sell £20 million annually through them. So hopefully we can do around £10. | boonboon | |
10/1/2019 08:30 | Patience is the key guys & holding your nerve. Why sell out when 1300 Boots stores are coming on stream? | molatovkid | |
10/1/2019 08:26 | Hi Rawnsley. Sorry to see you go. The drop not quite as bad as that (7%) and I'm not sure SD can be labelled as 'issues' (part and parcel of the move to Boots imo) as such but I can't blame anyone wanting to invest in something less volatile and with some actual positive financials! Keep looking in and hopefully you will see that it is darkest before dawn : ) | connor23 | |
10/1/2019 08:26 | Morning shake, up 10% on my morning buys. Statement really does not read that bad at all H1 revenues suffered but as expected. Growth in other areas is very good. Market is a foward looking mechanism worst out of the way with shareprice on lows can only mean higher prices going into financial results surely. | ileeman | |
10/1/2019 08:20 | Hc will maintain the illusion of growth as long as possible but the numbers don't lie. | gregpeck7 | |
10/1/2019 08:17 | Lemmings and mushrooms only now. Going down................ | ken chung | |
10/1/2019 08:15 | Bought a few more on the drop. I really dont see the issue but did expect the early drop because it seems people cannot read. Next set of results in about 1 month should trend higher. | ileeman | |
10/1/2019 08:09 | No positive surprise in TS so as you were post Sept H1 Rev warning. | connor23 | |
10/1/2019 08:05 | Traders getting shaken out on the headline figure, looks like a good move into next set of results tho. | ileeman | |
10/1/2019 08:04 | Mr Market usually right - Opened dwon 20% - Lots of Skin being burnt!! | pugugly | |
10/1/2019 08:04 | Worryingly they have not mentioned cash position | hamidahamida | |
10/1/2019 07:59 | Forward looking the future is bright, the market normally looks ahead. | doc robinson | |
10/1/2019 07:57 | Just saw SkinnyTan will be in an extra 55 boots stores than previously announced. It shows confidence by Boots. | boonboon | |
10/1/2019 07:56 | Skinny tan is still selling very well in Superdrug according to the staff | doc robinson | |
10/1/2019 07:55 | Despite the retail headwinds in the UK, sales through this channel grew by 36%, driven predominantly by the Roots brand which was launched 15 months ago. Pleasingly, during Christmas week, Roots delivered its best sales performance to date in Boots' stores whilst not on promotion. The Charles + Lee brand performed very well in Australia and delivered revenue growth of 50% compared to the same period last year. The brand has received CE Mark regulatory approval, enabling the brand to be marketed and sold within the EU. The Company is in early discussions with a number of UK retailers to range the brand. | ileeman | |
10/1/2019 07:52 | leeman....the way I read it yes. Far from catastrophic and with everything still to play for with the new distribution outlets and new products too. If this doesn't progress after Boots roll out then yes there is a problem but I doubt it. People trying to say Skinnytan is a busted flush already.....I dispute that too. It takes time to establish a brand. Once it gets more exposure the sales will fly.... | molatovkid | |
10/1/2019 07:49 | Week leading up to Christmas sales of roots in boots best ever and importantly with no offers. | doc robinson | |
10/1/2019 07:47 | Is everyone reading the same statement as me, surely slightly down H1 was expected but every other paragraph is bullish. Next results will light up the shareprice revenues expected to be much higher. | ileeman | |
10/1/2019 07:46 | My thoughts exactly Boon. Slightly disappointed but what I expected sums it up. We will have to wait until Feb for a bit more detail as per last year unfortunately. At least our expectations were managed this time around! | connor23 | |
10/1/2019 07:45 | boon....the only disappointment I read was the slight decline in direct sales, to be expected in the 2nd half of the year perhaps. Boots is the major positive and a step change in IDPs fortunes 'As indicated at our Annual General Meeting, we expect the second half of the year to be disproportionally higher than in previous years given the phasing of our substantially wider distribution network. We remain confident that that this will be a year of substantial growth across the business' | molatovkid | |
10/1/2019 07:45 | Cluthing at straws again. | rk23 | |
10/1/2019 07:41 | Let's not kid ourselves it's a slightly disappointing statement, but pretty much what I expected. In the short term it's all about the Boots deal.I have a feeling we're going to go in there in a big way. It's only just over a month away.Boots on it's own has the potential to do £10 million plus next financial year imo. | boonboon | |
10/1/2019 07:37 | Profit warning next muz as the decline really sets in. | gregpeck7 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions